Bausch Health Companies Inc (BHC)

[Pr0drIv3]

All the problems that valeant went through bring people to forget easily that it's still a 10 billion/year revenu company even with the huge debt and the judicial problems, it's huge.
The main reason the stock went down is the sales drop in the last quarter because otherwise, earning exceeded expectation.
Not to forget that valeant scaled up their sales force by 40% in the last months which will help to regain a good percentage of sales drop they have suffer.
Valeant has seen better days but it's definitly not over. Investor's will digest the news, like they did when everyone were bashing VRX 3 months ago, they will realised that the value of the company exceed it's current market cap and it'll rise again.

End of the story